Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Vinorelbine tartrate - Generic Drug Details

« Back to Dashboard
Vinorelbine tartrate is the generic ingredient in two branded drugs marketed by Jiangsu Hansoh Pharm, Ebewe Pharma, Actavis Totowa, Dr Reddys Labs Ltd, Hospira, Teva Pharms Usa, Mylan Labs Ltd, Fresenius Kabi Usa, Eurohlth Intl Sarl, and Pierre Fabre, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for vinorelbine tartrate. Eight suppliers are listed for this compound.

Summary for Generic Name: vinorelbine tartrate

Drug Master File Entries: see list14
Suppliers / Packaging: see list8
Drug Prices:see low prices

Pharmacology for Ingredient: vinorelbine tartrate

Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid

Clinical Trials for: vinorelbine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
vinorelbine tartrate
INJECTABLE;INJECTION076849-001Apr 18, 2005RXNo
Eurohlth Intl Sarl
vinorelbine tartrate
INJECTABLE;INJECTION076461-001Dec 11, 2003RXNo
Jiangsu Hansoh Pharm
vinorelbine tartrate
INJECTABLE;INJECTION091106-001Sep 26, 2012RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: vinorelbine tartrate

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pierre Fabre
vinorelbine tartrate
INJECTABLE;INJECTION020388-001Dec 23, 19944,307,100*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.